About 600 Sero-discordant couples where one partner is HIV positive and the other is not will take part in a new research study to help decide the best HIV Treatment Strategy that will reduce the rate of infection in the population.
A study by the National Agency for Control of AIDS (NACA) is to help decide whether health workers choose to administer the anti-retroviral drug, Trvada- as a prevention or treatment for HIV/AIDS.
Multiple studies have established that anti-retroviral drugs could be used to reduce the rate of infection in a population in two different ways, known by the acronyms PrEP (Pre-Exposure Prophylis) and TasP (Treatment as Prevention).